Cargando…

Report of Three Cases of Minimal Change Disease Following the Second Dose of mRNA SARS-CoV-2 COVID-19 Vaccine

Detalles Bibliográficos
Autores principales:	Salem, Fadi, Rein, Joshua L., Yu, Samuel Mon-Wei, Abramson, Mathew, Cravedi, Paolo, Chung, Miriam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313814/ https://www.ncbi.nlm.nih.gov/pubmed/34337193 http://dx.doi.org/10.1016/j.ekir.2021.07.017

Ejemplares similares

IgA Nephropathy After SARS-CoV-2 Vaccination
por: Abramson, Matthew, et al.
Publicado: (2021)

Letter regarding “Minimal change disease relapse following SARS-CoV-2 mRNA vaccine”
por: Schwotzer, Nora, et al.
Publicado: (2021)

A de novo case of minimal change disease following the first dose of the Moderna mRNA-1273 SARS-CoV-2 vaccine without relapse after the second dose
por: Mochizuki, Reika Ikegami, et al.
Publicado: (2022)

Aphasia seven days after second dose of an mRNA-based SARS-CoV-2 vaccine
por: Finsterer, Josef, et al.
Publicado: (2021)

Delayed skin reactions after the second dose of mRNA vaccines against SARS-CoV-2
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2022)

Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine
por: Tailor, Prashant D, et al.
Publicado: (2021)

Complement, a Therapeutic Target in Diabetic Kidney Disease
por: Budge, Kelly, et al.
Publicado: (2021)

Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine
por: Carli, Giuseppe, et al.
Publicado: (2021)

Acute myopericarditis and left shoulder capsulitis following second dose of mRNA SARS-CoV-2 Moderna vaccination
por: Quinodoz, Adrien, et al.
Publicado: (2023)

Safety and reactogenicity of second booster doses for mRNA vaccines
por: Wilder-Smith, Annelies, et al.
Publicado: (2023)

Evaluation of Immunogenicity to Three Doses of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Lung Transplant Patients
por: Guardiani, Mariasilvia, et al.
Publicado: (2022)

Su1489: HUMORAL IMMUNOGENICITY OF THREE SARS-COV-2 MRNA VACCINE DOSES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Schell, Trevor, et al.
Publicado: (2022)

Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals
por: Lozano-Ojalvo, Daniel, et al.
Publicado: (2021)

Incessant pericarditis following the second dose of SARS-CoV-2 mRNA vaccine successfully treated with anakinra: a case report
por: Conte, C, et al.
Publicado: (2022)

Durability and determinants of anti-SARS-CoV-2 spike antibodies following the second and third doses of mRNA COVID-19 vaccine
por: Yamamoto, Shohei, et al.
Publicado: (2023)

How important is the second dose of the COVID-19 mRNA vaccine?
por: Liu, Anne Y.
Publicado: (2021)

Minimal change disease relapse following SARS-CoV-2 mRNA vaccine
por: Kervella, Delphine, et al.
Publicado: (2021)

Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses
por: Almendro-Vázquez, Patricia, et al.
Publicado: (2022)

Innate immune responses to three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine
por: Saresella, Marina, et al.
Publicado: (2022)

Antibody Kinetics after Three Doses of SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease
por: Tsipotis, Evangelos, et al.
Publicado: (2023)

Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer
por: McKenzie, Duncan R., et al.
Publicado: (2021)

Long-Term Humoral Response After a Second Dose of SARS-CoV-2 mRNA Vaccine in Japanese Kidney Transplant Recipients
por: Ohki, Yutaro, et al.
Publicado: (2022)

Comparison of Humoral Response in Kidney Transplant Recipients and Donors and Healthy Volunteers Following Second Dose of SARS-CoV-2 mRNA Vaccine
por: Sasaki, Hajime, et al.
Publicado: (2023)

Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses
por: Schmiedeberg, Kristin, et al.
Publicado: (2022)

Temporal relation between second dose BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection
por: Ammirati, Enrico, et al.
Publicado: (2021)

Handling immune-suppressive therapies during SARS-CoV-2 pandemic: insights from pediatric datasets
por: Angeletti, Andrea, et al.
Publicado: (2020)

Fulminant myocarditis after the second dose of COVID‐19 mRNA vaccination
por: Oka, Akihiro, et al.
Publicado: (2022)

Reply to “How important is the second dose of the COVID-19 mRNA vaccine?”
por: Shaker, Marcus S., et al.
Publicado: (2021)

Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report
por: Kong, Joyce, et al.
Publicado: (2021)

Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine
por: Holzworth, Amy, et al.
Publicado: (2021)

Concurrent Antiglomerular Basement Membrane Nephritis and Antineutrophil Cytoplasmic Autoantibody–Mediated Glomerulonephritis After Second Dose of SARS-CoV-2 mRNA Vaccination
por: Gupta, Rajib K., et al.
Publicado: (2021)

Ultrasound-guided Cytopathologist Performed FNA Biopsy of Ipsilateral Trunk Lymphadenopathy Following Second Dose Administration of SARS-CoV-2 mRNA Vaccine
por: Memari, Patrick, et al.
Publicado: (2021)

Comparison of antibody response following the second dose of SARS-CoV-2 mRNA vaccine in elderly patients with late-stage chronic kidney disease
por: Matsunami, Masatoshi, et al.
Publicado: (2022)

Longitudinal humoral response in MS patients treated with cladribine tablets after receiving the second and third doses of SARS-CoV-2 mRNA vaccine()
por: Brill, Livnat, et al.
Publicado: (2022)

Diabetic ketoacidosis after the second dose of SARS-CoV-2 mRNA vaccination in a patient with pembrolizumab-induced fulminant type 1 diabetes
por: Nishino, Kohei, et al.
Publicado: (2022)

Tu1268: LONGITUDINAL ASSESSMENT OF SEROLOGICAL RESPONSE AFTER THREE DOSES OF SARS-COV-2 MRNA VACCINE IN LIVER TRANSPLANT RECIPIENTS
por: Gandle, Cassandra, et al.
Publicado: (2022)

WITHDRAWN: Temporal relation between second dose BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection
por: Ammirati, Enrico, et al.
Publicado: (2021)

Graves’ disease following administration of second dose of SARS-CoV-2 vaccine
por: Goblirsch, Timothy James, et al.
Publicado: (2021)

Effects of Second Dose of SARS-CoV-2 Vaccination on Household Transmission, England
por: Zaidi, Asad, et al.
Publicado: (2023)

Administration of the Second Dose of mRNA COVID-19 Vaccine to a Woman With Immediate Reaction to the First Dose
por: Apostolidou, Evaggelia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1dbgj7lbr29go0lc2q2c7aou0s